Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. Which patient- and ...

Circulating biomarkers exploratory study in loco-regional gastroesophageal adenocarcinoma patients. This is an ASCO Meeting Abstract from the 2017 Gastrointestinal Cancers Symposium. This abstract ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Genascence Corporation (“Genascence”), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, ...